Dynavax Technologies Corporation [DVAX] Director makes an insider sale of 3,000,000 shares worth 44,040,000.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Dynavax Technologies Corporation shares valued at $44,040,000 were sold by Hack Andrew A. F. on Aug 15. At $14.68 per share, Hack Andrew A. F. sold 3,000,000 shares. The insider’s holdings dropped to 5,415,000 shares worth approximately $54.53 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Also, Janssen Robert sold 7,938 shares, netting a total of over 134,277 in proceeds. Following the sale of shares at $16.92 each, the insider now holds 35,519 shares.

Before that, Novack David F had sold 26,250 shares from its account. In a trade valued at $444,037, the President & COO traded Dynavax Technologies Corporation shares for $16.92 each. Upon closing the transaction, the insider’s holdings decreased to 26,250 shares, worth approximately $0.54 million.

Analysts at Goldman started covering the stock with ‘”a Buy”‘ outlook in a report released in early August. As of August 07, 2020, H.C. Wainwright has reiterated its “Buy” rating for DVAX. Earlier on August 03, 2020, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for DVAX stock.

Analyzing DVAX’s Price Performance

On Wednesday, Dynavax Technologies Corporation [NASDAQ: DVAX] plunged -2.89% to $10.07. The stock’s lowest price that day was $10.07, but it reached a high of $10.50 in the same session. During the last five days, there has been a drop of approximately -12.81%. Over the course of the year, Dynavax Technologies Corporation shares have dropped approximately -28.43%. Shares of the company reached a 52-week high of $17.48 on 08/10/22 and a 52-week low of $7.26 on 05/12/22. A 50-day SMA is recorded $13.25, while a 200-day SMA reached $12.21. Nevertheless, trading volume fell to 1.76 million shares from 1.52 million shares the previous day.

Support And Resistance Levels for Dynavax Technologies Corporation (DVAX)

According to the 24-hour chart, there is a support level at 9.93, which, if violated, would cause prices to drop to 9.78. In the upper region, resistance lies at 10.36. The next price resistance is at 10.64. RSI (Relative Strength Index) is 30.85 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.80, which suggests the price will decrease in the coming days. Percent R is at 100.00%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.

Is Dynavax Technologies Corporation subject to short interest?

Stocks of Dynavax Technologies Corporation saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.13 million shares to 19.38 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 19.51 million shares. A decline of -0.67% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.68 of the overall float, the days-to-cover ratio (short ratio) decline to 10.68.

Which companies own the most shares of Dynavax Technologies Corporation (DVAX)?

In terms of Dynavax Technologies Corporation share price expectations, FactSet research, analysts set an average price target of $25.50 in the next 12 months, up nearly 150.72% from the previous closing price of $10.37. Analysts anticipate Dynavax Technologies Corporation stock to reach $30.00 by 2022, with the lowest price target being $20.00. In spite of this, 5 analysts ranked Dynavax Technologies Corporation stock as a Buy at the end of 2022. On June 15, 2020, Evercore ISI assigned a price target of “an Outperform” to the stock and initiated coverage with a $14.

LEAVE A REPLY

Please enter your comment!
Please enter your name here